![](/img/cover-not-exists.png)
PCN48 ECONOMIC BURDEN ASSOCIATED WITH SEVERE ADVERSE EVENTS IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
Lejeune, D., Pavilack, M., Dersarkissian, M., Fernandes, A., Duh, M.S., Subramanian, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.172
Date:
May, 2019
File:
PDF, 649 KB
2019